
Creo Medical Group Plc
(LSE) CREO
Creo Medical Group Plc Financials at a Glance
Market Cap
£61.08M
Revenue (TTM)
£36.30M
Net Income (TTM)
-£17.10M
EPS (TTM)
£0.01
P/E Ratio
10.62
Dividend
£0.00
Beta (Volatility)
0.00 (Low)
Dividend
£0.00
Beta (Volatility)
0.00 (Low)
Price
£0.13
Volume
1,223,872
Open
£0.13
Price
£0.13
Volume
1,223,872
Open
£0.13
Previous Close
£0.13
Daily Range
£0.13 - £0.14
52-Week Range
£0.10 - £0.19
Estimated Earnings Date
Sep 30, 2026
Dividend
£0.00
Beta (Volatility)
0.00 (Low)
Price
£0.13
Volume
1,223,872
Open
£0.13
Previous Close
£0.13
Daily Range
£0.13 - £0.14
52-Week Range
£0.10 - £0.19
Estimated Earnings Date
Sep 30, 2026
CREO News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Creo Medical Group Plc
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
109
CEO
Craig Jonathan Gulliford
Website
www.creomedical.comHeadquarters
Chepstow, NP16 5UH, GB
CREO Financials
Key Financial Metrics (TTM)
Gross Margin
32%
Operating Margin
-3%
Net Income Margin
88%
Return on Equity
0%
Return on Capital
-40%
Return on Assets
9%
Earnings Yield
9.42%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
£61.08M
Shares Outstanding
449.14M
Volume
1.22M
Avg. Volume
723.65K
Financials (TTM)
Gross Profit
£1.40M
Operating Income
-£20.70M
EBITDA
-£19.70M
Operating Cash Flow
-£18.60M
Capital Expenditure
£0.00
Free Cash Flow
-£18.60M
Cash & ST Invst.
£12.40M
Total Debt
£4.10M
Creo Medical Group Plc Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
£3.80M
-75.8%
Gross Profit
£900.00K
-84.5%
Gross Margin
23.68%
N/A
Market Cap
£61.08M
N/A
Market Cap/Employee
£219.72K
N/A
Employees
278
N/A
Net Income
-£11.60M
+0.0%
EBITDA
-£10.20M
+10.5%
Quarterly Fundamentals
Total Cash
£12.40M
-33.0%
Total Debt
£4.10M
-50.6%
Accounts Receivable
£6.90M
-12.7%
Inventory
£2.50M
-69.1%
Long Term Debt
£1.80M
-65.4%
Short Term Debt
£2.30M
-25.8%
Return on Assets
8.97%
N/A
Return on Invested Capital
-39.96%
N/A
Free Cash Flow
-£34.20M
-375.0%
Operating Cash Flow
-£34.20M
-434.4%